Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Clinical implications of arrest-defective protein 1 expression in hepatocellular carcinoma: a novel predictor of microvascular invasion.

Shim JH, Chung YH, Kim JA, Lee D, Kim KM, Lim YS, Lee HC, Lee YS, Yu E, Lee YJ.

Dig Dis. 2012;30(6):603-8. doi: 10.1159/000343090. Epub 2012 Dec 13.

PMID:
23258102
2.

The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.

Chen D, Xing W, Hong J, Wang M, Huang Y, Zhu C, Yuan Y, Zeng W.

Ann Surg Oncol. 2012 Oct;19(11):3556-65. doi: 10.1245/s10434-012-2396-1. Epub 2012 May 17.

PMID:
22588469
3.

Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma.

Ng KT, Qi X, Kong KL, Cheung BY, Lo CM, Poon RT, Fan ST, Man K.

Eur J Cancer. 2011 Oct;47(15):2299-305. doi: 10.1016/j.ejca.2011.05.032. Epub 2011 Jun 15.

PMID:
21683576
4.

Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.

Zhan DQ, Wei S, Liu C, Liang BY, Ji GB, Chen XP, Xiong M, Huang ZY.

J Gastroenterol Hepatol. 2012 Jan;27(1):173-80. doi: 10.1111/j.1440-1746.2011.06847.x.

PMID:
21777276
5.

Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy.

Yuan SX, Yang F, Yang Y, Tao QF, Zhang J, Huang G, Yang Y, Wang RY, Yang S, Huo XS, Zhang L, Wang F, Sun SH, Zhou WP.

Hepatology. 2012 Dec;56(6):2231-41. doi: 10.1002/hep.25895.

PMID:
22706893
6.

Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation.

Han ZB, Chen HY, Fan JW, Wu JY, Tang HM, Peng ZH.

J Cancer Res Clin Oncol. 2012 Jan;138(1):153-61. doi: 10.1007/s00432-011-1076-z. Epub 2011 Nov 10.

PMID:
22071603
7.

[OCT4 expression in hepatocellular carcinoma and its clinical significance].

Huang PZ, Lu CL, Li BK, Hong J, Huang L, Wang L, Zhang Y, Yuan YF.

Chin J Cancer. 2010 Jan;29(1):111-16. Chinese.

8.

Expression and prognostic significance of CIP2A mRNA in hepatocellular carcinoma and nontumoral liver tissues.

Huang P, Qiu J, You J, Hong J, Li B, Zhou K, Chen G, Yuan Y, Zou R.

Biomarkers. 2012 Aug;17(5):422-9. doi: 10.3109/1354750X.2012.680608. Epub 2012 Apr 27.

PMID:
22537152
9.

The gene expression level of transforming growth factor-beta (TGF-beta) as a biological prognostic marker of hepatocellular carcinoma.

Ikeguchi M, Iwamoto A, Taniguchi K, Katano K, Hirooka Y.

J Exp Clin Cancer Res. 2005 Sep;24(3):415-21.

PMID:
16270528
10.

Role of the hypoxia-related gene, JMJD1A, in hepatocellular carcinoma: clinical impact on recurrence after hepatic resection.

Yamada D, Kobayashi S, Yamamoto H, Tomimaru Y, Noda T, Uemura M, Wada H, Marubashi S, Eguchi H, Tanemura M, Doki Y, Mori M, Nagano H.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S355-64. doi: 10.1245/s10434-011-1797-x. Epub 2011 May 24.

PMID:
21607773
11.

The role of MTA1 gene expression in human hepatocellular carcinoma.

Hamatsu T, Rikimaru T, Yamashita Y, Aishima S, Tanaka S, Shirabe K, Shimada M, Toh Y, Sugimachi K.

Oncol Rep. 2003 May-Jun;10(3):599-604.

PMID:
12684630
12.

Predictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resection.

Eguchi S, Takatsuki M, Hidaka M, Soyama A, Tomonaga T, Muraoka I, Kanematsu T.

World J Surg. 2010 May;34(5):1034-8. doi: 10.1007/s00268-010-0424-5.

PMID:
20127241
13.

LAMA4, highly expressed in human hepatocellular carcinoma from Chinese patients, is a novel marker of tumor invasion and metastasis.

Huang X, Ji G, Wu Y, Wan B, Yu L.

J Cancer Res Clin Oncol. 2008 Jun;134(6):705-14. Epub 2007 Dec 14.

PMID:
18084776
14.

Overexpression of renal tumor antigen is associated with tumor invasion and poor prognosis of hepatocellular carcinoma.

Cha HJ, Kim J, Hong SM, Hong SJ, Park JH, Kim ES, Wang HJ, Choi YJ, Do IG, Joh JW, Kim DS, Choi KY.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S404-11. doi: 10.1245/s10434-011-1856-3. Epub 2011 Jun 30. Erratum in: Ann Surg Oncol. 2011 Dec;18 Suppl 3:S321.

PMID:
21717246
15.

Downregulation of MAGI1 associates with poor prognosis of hepatocellular carcinoma.

Zhang G, Liu T, Wang Z.

J Invest Surg. 2012 Apr;25(2):93-9. doi: 10.3109/08941939.2011.606875. Epub 2011 Sep 26.

PMID:
21942217
16.

[The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].

Liu Y, Chen X, Peng S, Fang H, Wu Y, Peng C, Shi L, Bai M, Xu B, Wang J, Deng G.

Zhonghua Yi Xue Za Zhi. 2002 Nov 25;82(22):1553-6. Chinese.

PMID:
12609066
17.

Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis.

Kim J, Hong SJ, Lim EK, Yu YS, Kim SW, Roh JH, Do IG, Joh JW, Kim DS.

J Exp Clin Cancer Res. 2009 Feb 16;28:20. doi: 10.1186/1756-9966-28-20.

18.

Characterization of somatostatin receptor 2 and 5 expression in operable hepatocellular carcinomas.

Li S, Liu Y, Shen Z.

Hepatogastroenterology. 2012 Oct;59(119):2054-8.

PMID:
22640914
19.

Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico-pathological parameters.

Kanda M, Nomoto S, Nishikawa Y, Sugimoto H, Kanazumi N, Takeda S, Nakao A.

J Surg Oncol. 2008 Sep 1;98(3):190-6. doi: 10.1002/jso.21095.

PMID:
18537151
20.

Primary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survival.

Moon JI, Kwon CH, Joh JW, Choi GS, Jung GO, Kim JM, Shin M, Choi SJ, Kim SJ, Lee SK.

Transplant Proc. 2012 Mar;44(2):487-93. doi: 10.1016/j.transproceed.2011.11.009.

PMID:
22410053
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk